Thursday, November 3, 2016 | 9:00 AM - 5:00 PM
Speakers: Henrik Bjørn Nielsen (Clinical-Microbiomics A/S), Martin J. Blaser (New York University Langone Medical Center), Patrice D. Cani (Universite Catholique de Louvain, LDRI), Rachel Carmody (Harvard University), Stanley L. Hazen (Cleveland Clinic), Gerald I. Shulman (Yale University School of Medicine), Marion Soto (Joslin Diabetes Center, Harvard Medical School), and Dan Winer (University of Toronto)
The microbiome is emerging as an important regulator of health, and disease well beyond the digestive tract. This symposium will highlight recent research innovations and therapeutic applications from the microbiome with a focus on metabolic disease.
Saturday, January 28, 2017 | 11:00 AM - 4:00 PM
This event gives professionals from across the biopharmaceutical space — from scientists and industry executives, through healthcare providers and insurers to investors — a visceral understanding of how biopharma innovation dynamics are evolving, mimicking decision-making under pressure in a complex and changing environment.
Monday, March 13, 2017 | 8:30 AM - 6:00 PM
Speakers: Michael G. Agadjanyan (The Institute for Molecular Medicine), Andreas Muhs (AC Immune SA), Michal Novák (AXON Neuroscience SE), Einar M. Sigurdsson (NYU School of Medicine), Henrik Zetterberg (University of Gothenburg, Sweden), and Khalid Iqbal (New York State Institute for Basic Research)
This event will cover the translational potential of immunotherapy for tauopathies, reviewing the pre-clinical and clinical development of several tau immunotherapy programs that exemplify this emerging therapeutic approach.
Tuesday, April 11, 2017 | 9:00 AM - 5:00 PM
Speakers: Brian Kaspar (Nationwide Children's Hospital), R. Jude Samulski (Bamboo Therapeutics), Barry Byrne (University of Florida, Powell Gene Therapy Center), Maria Escolar (Children's Hospital of Pittsburgh), Jakub Tolar (University of Minnesota), Kevin Flanigan (Nationwide Children's Hospital), Katherine A. High (Spark Therapeutics), and David Pearce (Sanford Research)
Gene therapy has been proposed as a promising therapeutic strategy for monogenic disorders. This symposium will explore recent advances in field, and identify ongoing obstacles on the path to wider use of this approach.
May 15 - 17, 2017
Keynote Speaker: Vijay K. Kuchroo, DVM, PhD, Harvard Institutes of Medicine
Learn about most recent advances in basic, translational, and clinical research on the rare, acquired disorder, Myasthenia Gravis, as well as implications of this research on a range of related autoimmune and neuromuscular diseases.
September 21 - 23, 2016
Featuring: Peder S. Olofsson (Karolinska Institutet) and Kevin J. Tracey (The Feinstein Institute for Medical Research)
Bioelectronic medicine, a new discipline aimed at interfacing electronics with cells to target molecular mechanisms, is at the epicenter of healthcare, technology, and science. This symposium will advance the technological promise of bioelectronics.
Tuesday, June 28, 2016 | 8:00 AM - 5:30 PM
Keynote Speaker: Giancarlo Comi (Università Vita-Salute San Raffaele)
Explore novel and emerging treatments for multiple sclerosis, including biomarkers and MRI usage in disease diagnosis, prognosis, and monitoring.
Wednesday, May 25, 2016 | 11:30 AM - 5:00 PM
Speakers: Philip A. Cole (Johns Hopkins University School of Medicine), Kenneth W. Duncan (Epizyme, Inc.)
The Chemical Biology Discussion Group brings together chemists and biologists interested in discussing the latest breakthroughs. In 2016, the annual year-end meeting features keynote speakers Dr Philip Cole and Dr Kenneth Duncan.
May 18 - 20, 2016
Keynote Speakers: Nora D. Volkow (National Institute on Drug Abuse, U.S. National Institutes of Health), George F. Koob (National Institute on Alcohol Abuse and Alcoholism, U.S. National Institutes of Health), and The Honorable Patrick J. Kennedy (Former United States Representative, Rhode Island; Co-Founder, One Mind; and Founder, Kennedy Forum)
Discover from leading experts, including NIAAA and NIDA directors, the latest on neurobiology of addiction; susceptibility of the teen brain; new treatment strategies; and social, economic, political, and legislative aspects of this disease.
Edited by Jeffrey D. Laskin
(Rutgers University School of Public Health)
Discussions of various countermeasures to chemical threats.
Edited by Mone Zaidi
(Mount Sinai School of Medicine, New York, New York)
Original research and review manuscripts covering topics in basic and translational bone and bone marrow biology.
Keynote Speakers: Richard Gilbertson (Cambridge Cancer Centre, University of Cambridge, UK) and Craig B. Thompson (Memorial Sloan Kettering Cancer Center)
This eBriefing covers the latest research on pediatric cancers.
Organizers: Donald McCaffery (Resverlogix Corp.), Norman Wong (Resverlogix Corp.), Sarah Zapotichny (Resverlogix Corp.), George Zavoico (Jones Trading Institutional Services), Sonya Dougal (The New York Academy of Sciences), and Caitlin McOmish (The New York Academy of Sciences)
Keynote Speaker: Craig B. Thompson (Memorial Sloan Kettering Cancer Center)
Epigenetic abnormalities contribute to tumorigenesis and various diseases beyond cancer. This eBriefing describes recent progress in validating the therapeutic potential of small molecule inhibitors targeting epigenetic marks.